IDH1 and malignant glioma: Furthermore, high ZDHHC15 expression was more prevalent in malignant glioma subtypes, including recurrence, IDH wild-type, and 1p/19q non-codeletion (Fig. 1E-G), which are considered markers of a poor prognosis [26, 27].